IP Library Assignment 035793/0752
Patent Assignment
Reel/Frame 035793/0752

Assignment of Assignor's Interest

Recorded: 2015-06-05 Pages: 3
Assignor
BROWN, ARTHUR M.
Executed: 2012-12-05
Assignee
CHANRX CORPORATION
14656 NEO PARKWAY, CLEVELAND, OHIO, 44128
Covered Properties (3)
Novel Piperazine Compounds, Pharmaceutical Compositions Containing the Same and Methods of Terminating Acute Episodes of Cardiac Arrhythmia, Restoring Normal Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia and Maintaining Normal Sinus Rhythm in Mammals
Application: 14/437,485 →
Publication: US 2015/0336917
Pharmaceutical Compositions Containing Piperazine Compounds in Combination with a P450 Inhibitor and Methods of Terminating Acute Episodes of Cardiac Arrhythmia, Restoring Normal Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia and Maintaining Normal Sinus Rhythm in Mammals Through Administration of Said Compositions
Application: 14/437,490 →
Publication: US 2015/0283131
Pharmaceutical Compositions Containing Enantiomerically Pure and/or Racemic Mixtures of Chiral Piperazine Compounds and Methods of Terminating Acute Episodes of Cardiac Arrhythmia, Restoring Normal Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia and Maintaining Normal Sinus Rhythm in Mammals Through Administration of Said Compositions
Application: 14/437,493 →
Publication: US 2015/0290188
Related Assignments (1)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name May 21, 2015
From: CHANRX CORP.
To: LAGUNA PHARMACEUTICALS, INC.
Reel/Frame 035750/0951 →